Not all individuals with CLL require therapy. Despite all the latest advances, the iwCLL however endorses watchful observation for patients with asymptomatic disease.86 This advice is predicated on at the very least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both equally trials https://kated197aiq4.thenerdsblog.com/profile